Actively Recruiting
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Led by Georgetown University · Updated on 2025-08-28
332
Participants Needed
2
Research Sites
239 weeks
Total Duration
On this page
Sponsors
G
Georgetown University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally-targeted video and referral screening tool. In this study, the investigators aim to evaluate the efficacy of a culturally targeted video previously developed by the research team vs. a Spanish-language fact sheet from an established group on enhancing genetic counseling and testing uptake and psychosocial outcomes in Latina women at risk for hereditary breast and ovarian cancer. The investigators will test the video's efficacy while also gathering data on the implementation and future sustainability of using the Risk Screening Tool (RST) and video in community clinics.
CONDITIONS
Official Title
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identify as a Latina woman
- Be 18 years old or older
- Be able to provide informed consent
- Be fluent in Spanish
- Meet NCCN criteria for genetic cancer risk assessment for HBOC by personal or family cancer history
- Have no previous genetic counseling or testing for hereditary breast and ovarian cancer risk
- Have no other family members participating in this study
- Have not participated in previous studies involving interventions about HBOC or genetic counseling and testing
- Be 18 years old or older (for community clinic staff)
- Be fluent in English or Spanish (for community clinic staff)
- Have a role in the partner community clinic as full-time or part-time employee, intern, or volunteer (for community clinic staff)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, United States, 20007
Actively Recruiting
2
Virginia Commonwealth University
Richmond, Virginia, United States, 23284
Actively Recruiting
Research Team
A
Alejandra Hurtado de Mendoza, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here